ALT 8-K 2026-08-12

Altimmune, Inc. (ALT) 8-K dated 2026-08-12 — accession 0001326190-26-000049. This URL is the filing, not the ALT hub.

Altimmune, Inc. (ALT) is a biotechnology company listed on US.

Altimmune, Inc. filed a 8-K on 2026-08-12. Accession 0001326190-26-000049.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ALT revenue for 2025-09-30 was $5.0K. Net income was -$60.7M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. ALT currently screens at market cap $527.0M.

Not investment advice. The ALT SEC hub lists recent forms. The stock page is the research view.